The potential risk of AVM rupture was evaluated within the A Randomized demo of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This research disclosed a reduced possibility of stroke and mortality in individuals managed conservatively as opposed to individuals who underwent interventional therapy.[thirteen]  The ARUBA demo in comparison healthcare management by https://www.sgvascularctr.com/service/vascular-malformations/